Disarm Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

Disarm Therapeutics is a Cambridge, Massachusetts–based biotechnology company focused on preventing axonal degeneration, a key factor in many neurological diseases. Its work aims to develop therapeutics that inhibit the SARM1 protein, with the goal of preserving axons in a range of central, ocular, and peripheral nervous system conditions such as multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and various neuropathies. The company treats researchers and clinicians as its primary audience, seeking disease-modifying interventions that address the progression and disability associated with neurodegenerative disorders. Founded by a group of scientists and drug developers, including collaborators from prominent academic institutions, Disarm Therapeutics positions itself within the biotechnology research sector as a developer of new therapeutic approaches for neurological diseases. A recent development noted in industry coverage highlights the company’s acquisition activity by a major pharmaceutical partner, reflecting its status within the competitive landscape of neurodegenerative therapeutics.

Sign up for free to view info

Company overview Email format